When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Breakthrough antidepressants with fewer side effects could ...

   www.aol.com/finance/breakthrough-antidepressants...

   But the newest available treatments—and those on the horizon—are finding success by approaching that target from an entirely different angle. The history of antidepressants

3. FDA approves Johnson & Johnson’s ketamine-derived ... - AOL

   www.aol.com/finance/fda-approves-johnson-johnson...

   According to the news release, patients can expect to see improvements in depressive symptoms in 28 days—and maybe as quickly as 24 hours—without also relying on daily antidepressant pills.

4. FDA approves standalone use of J&J’s ketamine-derived ... - AOL

   www.aol.com/news/fda-approves-standalone-j-j...

   The ketamine-derived drug was first approved in 2019 to be used in combination with antidepressants, and later for patients experiencing suicidal thoughts or actions. ... For more CNN news and ...

5. List of antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_antidepressants

   This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification. Chemical/generic names are listed first, with brand names in parentheses.

6. Development and discovery of SSRI drugs - Wikipedia

   en.wikipedia.org/wiki/Development_and_discovery...

   SSRIs have dominated the market for antidepressants [1] and are recommended by the National Institute for Health and Clinical Excellence (NICE) as a first-line treatment of depression, because they tend to have fewer adverse effects than other type of antidepressants with the same effectiveness. [4]

7. List of investigational antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_investigational...

   This is a list of investigational antidepressants, or drugs that are currently under development for clinical use in the treatment of depression but are not yet approved. Specific indications include major depressive disorder , treatment-resistant depression , dysthymia , bipolar depression , and postpartum depression , among others.